Transaction DateRecipientSharesTypePriceValue
2nd October 2020Leslie D. Funtleyder5,976Open or private sale$20.07$119,938.32
1st October 2020Leslie D. Funtleyder30,000Exercise of derivative$4.70$141,000.00
1st October 2020Leslie D. Funtleyder22,671Open or private sale$20.03$454,100.13
1st October 2020Leslie D. Funtleyder1,353Open or private sale$20.75$28,074.75
24th August 2020Leslie D. Funtleyder13,539Open or private sale$23.42$317,083.38
24th August 2020Leslie D. Funtleyder6,461Open or private sale$24.18$156,226.98
21st August 2020Leslie D. Funtleyder20,000Exercise of derivative$4.70$94,000.00
17th August 2020Joel S Marcus3,500Open or private sale$173.51$607,285.00
17th August 2020Joel S Marcus4,000Open or private sale$171.52$686,080.00
12th August 2020Joel S Marcus7,959Open or private sale$14.15$112,619.85
Applied Therapeutics
Applied Therapeutics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company was founded by Shoshana Shendelman on January 20, 2016.

Ticker: APLT
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1697532
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags